About Me
Attention All Shingles Sufferers!
GLAXOSMITHKLINE announced that it will file for formal approval with the UK, the US, and Japan for the Shingles Vaccine, Shingrix in 2016.
It is in phase 3 (human testing) with a 97.2% efficacy rate, whereas Merck's Zostavax rate was in the 53% range, dropping in efficacy if age >70 years to 37%. Obviously, this is a vast improvement. Also, as this is a killed virus with an adjuvant, it can be given to immunocompromised patients. This was not tested on patients who have already had shingles, however.
Great news for all of us as it may help you.
Recent Replies
Shingles Nausea after the outbreak, Dear Robert, I am so sorry that you …
Shingles Nausea after the outbreak, Dear Robert, I am so sorry you are …
Breast lump, Dear Pauline, I am hoping with the …
Opinion - Cancer or Fibroadenoma? Pics of ultrasound, Dear Jess, I am sorry you are dealing …
Opinion - Cancer or Fibroadenoma? Pics of ultrasound, Dear Jess, I am sorry you are dealing …
Breast lump, Dear Pauline, I am well now! I left …
Breast lump, Pauline, When issues have come up for …
Breast lump, Dear Pauline, Wonderful news! Let me …
Breast lump, Your Welcome, Pauline Pauline was my …
Breast lump, Dear Pauline, I am sorry you have …